Experimental study of non-alcoholic fatty liver disease (NAFLD) on a model of starving chickens: Is generalization of steatosis accompanied by fibrosis of the liver tissue?

Pathology Research and Practice

Volumn 207, Issue 3, 2011, Pages 151-155

  Makovicky, Peter ^a   Dudova, Marketa ^a   Tumova, Eva ^a   Rajmon, Radko ^a   Vodkova, Zuzana ^a  

^a CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

Author keywords

Hyperemia; Lipids; Metabolism; NASH; Nutrition; Restriction; Starvation

Indexed keywords

COLLAGEN TYPE 1; RETICULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CELL SIZE; CHICKEN; CONTROLLED STUDY; DIET RESTRICTION; EXPERIMENTAL STUDY; FATTY LIVER; GENETIC VARIABILITY; HEPATITIS; HISTOPATHOLOGY; INTERSTITIUM; LIVER CELL; LIVER FIBROSIS; LIVER PARENCHYMA; MICROVASCULATURE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; SEX DIFFERENCE; STARVATION;

AGE FACTORS; AGING; ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; CALORIC RESTRICTION; CELL SIZE; CHICKENS; DISEASE PROGRESSION; FATTY LIVER; FEMALE; GENOTYPE; HEPATOCYTES; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PHENOTYPE; SEX FACTORS; STARVATION;

EID: 79952455233     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.12.002     Document Type: Article

References (54)

1. Angulo P., Hui J.M., Marchesini G., Bugianesi E., George J., Farrell G.C., Enders F., Saksena S., Burt A.D., Bida J.P., Lindor K., Sanderson S.O., Lenzi M., Adams L.A., Kench J., Therneau T.M., Day C.P. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007, 45:846-854.
2. Ayala I., Castillo A.M., Adánez G., Fernández-Rufete A., Pérez B.G., Castells M.T. Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis. Exp. Biol. Med. (Maywood) 2009, 234:10-16.
3. Barshop N.J., Sirlin C.B., Schwimmer J.B., Lavine J.E. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol. Ther. 2008, 28:13-24.
4. Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005, 115:209-218.
5. Benyon R.C., Iredale J.P. Is liver fibrosis reversible?. Gut 2000, 46:443-446.
6. Brunt E.M. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001, 21:3-16.
7. Brunt E.M., Kleiner D.E., Wilson L.A., Unalp A., Behling C.E., Lavine J.E., Neuschwander-Tetri B.A. NAFLD-clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009, 49:809-820.
8. Castera L. Non-invasive diagnosis of steatosis and fibrosis. Diab. Metab. 2008, 34:674-679.
9. Day C.P. Pathogenesis of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 2002, 16:663-678.
10. Day C.P. From fat to inflammation. Gastroenterology 2006, 130:207-210.
11. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 2005, 115:1139-1142.
12. Erickson S.K. Nonalcoholic fatty liver disease. J. Lipid Res. 2009, 50:S412-S416.
13. Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43:99-112.
14. Gramlich T., Kleiner D.E., McCullough A.J., Matteoni C.A., Boparai N., Younossi Z.M. Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum. Pathol. 2004, 35:196-199.
15. Grattagliano I., Vendemiale G., Caraceni P., Domenicali M., Nardo B., Cavallari A., Trevisani F., Bernardi M., Atomare E. Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet. J. Nutr. 2000, 130:2131-2136.
16. Guzman G., Brunt E.M., Petrovic L.M., Chejfec G., Layden T.J., Cotler S.J. Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirhosis?. Arch. Pathol. Lab. Med. 2008, 132:1761-1766.
17. Hernandez-Espinosa D., Ayala I., Castells M.T., Garcia-Pérez B., Martín-Castillo A., Miňano A., Arcas I., Vicente V., Corral J. Intracellular retention of hepatic serpins caused by severe hyperlipidemia. Liver Int. 2006, 26:708-715.
18. Charlton M. Noninvasive indicies of fibrosis in NAFLD: starting to think about a three-hit (at least) phenomenon. Am. J. Gastroenterol. 2007, 102:409-411.
19. Chaves-Tapia N.C., Uribe M., Ponciano-Rodrigues G., Medina-Santillan R., Mendez-Sanchez N. New insight into the pathophysiology of nonalcoholic fatty liver disease. Ann. Hepatol. 2009, 8:9-17.
20. Issa R., Zhou X., Constandinou C.M., Fallowfield J., Millward-Sadler H., Gaca M.D., Sands E., Suliman I., Trim N., Knorr A., Arthur M.J., Benyon R.C., Iredale J.P. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 2004, 126:1795-1808.
21. Junqueira L.C., Bignolas G., Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue section. Histochem. J. 1979, 11:447-455.
22. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
23. Lazo M., Clark J.M. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008, 28:339-350.
24. Le T.H., Caldwell S.H., Redick J.A., Sheppard B.L., Davis C.A., Arseneau K.O., Iezzoni J.C., Hespenheide E.E., Al-Osaimi A., Peterson T.C. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 2004, 39:1423-1429.
25. Lim Y.S., Kim W.R. The global impact of hepatic fibrosis and end-stage liver disease. Clin. Liver Dis. 2008, 12:733.
26. Maislos M., Medvedovsky V., Sztarkier I., Yaari A., Sikuler E. Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease. Diab. Rec. Clin. Pract. 2006, 72:1-5.
27. Mazhar S.M., Shiehmorteza M., Sirlin C.B. Noninvasive assessment of hepatic steatosis. Clin. Gastroenterol. Hepatol. 2009, 7:135-140.
28. Miele L., Forgione A., Gasbarrini G., Grieco A. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Transl. Res. 2007, 149:114-125.
29. Mittendorfer B., Jeschke M.G., Wolf S.E., Sidossis L.S. Nutritional hepatic steatosis and mortality after burn injury in rats. Clin. Nutr. 1998, 17:293-299.
30. Papandreou D., Rousso I., Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clin. Nutr. 2007, 26:409-415.
31. Paradis V., Bedossa P. Definition and natural history of metabolic steatosis: histology and cellular aspects. Diab. Metab. 2008, 34:638-642.
32. Paschos P., Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 2009, 13:9-19.
33. Patton H.M., Sirlin C., Behling C., Middleton M., Schwimmer J.B., Lavine J.E. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J. Pediatr. Gastroenterol. Nutr. 2006, 43:413-427.
34. Preiss D., Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin. Sci. (Lond.) 2008, 115:141-150.
35. Ramos-De la Medina A., Remes-Troche J.M., Roesch-Dietlen F.B., Pérez-Morales A.G., Martinez S., Cid-Juarez S. Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystoctomy for gallstone disease: is it justifed?. J. Gastrointest. Surg. 2008, 12:2097-2102.
36. Rautou P.E., Cazals-Hatem D., Moreau R., Francoz C., Feldmann G., Lebrec D., Ogier-Denis E., Bedossa P., Valla D., Durand F. Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology 2008, 135:840-848.
37. Serfaty L., Lemoine M. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD NASH and cirrhosis. Diab. Metabol. 2008, 34:634-637.
38. Sevastianos V.A., Hadziyannis S.J. Nonalcoholic fatty liver disease: from clinical recognition to treatment. Exp. Rev. Gastroenterol. Hepatol. 2008, 2:59-79.
39. Schattenberg J.M., Galle P.R. Animal models of non-alcoholic steatohepatitis: of mice and man. Dig. Dis. 2010, 28:247-254.
40. Sokolovic M., Sokolovic A., Roomen van C.P.A.A., Gruber A., Ottenhoff R., Scheij S., Hakvoort T.B.M., Lamers W.H., Groen A.K. Unexpected effects of fasting on murine lipid homeostasis-transcriptomic and lipid profiling. J. Hepatol. 2010, 52:737-744.
41. Talwalkar J.A. Motion-all patients with NASH need to have a liver biopsy: arguments for the motion. Can. J. Gastroenterol. 2002, 16:718-721.
42. Tarantino G. Non-alcoholic fatty liver disease, obesity and other illness. Clin. Invest. Med. 2008, 31:290-295.
43. Tessari P., Coracina A., Cosma A., Tiengo A. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 2009, 19:291-302.
44. van Ginneken V.J. Liver fattening during feast and famine: an evolutionary paradox. Med. Hypotheses 2008, 70:924-928.
45. Vasdev N., Kakati A.G., Saigal S., Nayak N.C. Spectrum of histological features in non-alcoholic fatty liver disease. Natl. Med. J. India 2007, 20:282-287.
46. Watanabe S., Horie Y., Kataoka E., Sato W., Dohmen T., Ohshima S., Goto T., Suzuki A. Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphate and tensin homolog (PTEN)-deficient mice. J. Gastroenterol. Hepatol. 2007, 22:S96-S100.
47. Watt M.J., Steinberg G.R. Regulation and function of triacylglycerol lipases in cellular metabolism. Biochem. J. 2008, 414:313-325.
48. Wieckowska A., Feldstein A.E. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis. 2008, 28:386-395.
49. Wu H.S., Fiel M.I., Schiano T.D., Gil J. Image segmentation of liver fibrosis. J. Microsc. 2008, 231:70-80.
50. Yeh M.M., Brunt E.M. Pathology of nonalcoholic fatty liver disease. Am. J. Clin. Pathol. 2007, 128:837-847.
51. Yu A.S., Keeffe E.B. Nonalcoholic fatty liver disease. Rev. Gastroenterol. Disord. 2002, 2:11-19.
52. Younossi Z.M. Nonalcoholic fatty liver disease. Curr. Gastroenterol. Rep. 1999, 1:57-62.
53. Younossi Z.M. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol. Ther. 2008, 1:2-12.
54. Zou Y., Li J., Lu C., Wang J., Ge J., Huang Y., Zhang L., Wang Y. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 2006, 79:1100-1107.